NCT04298541 - Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC | Biotech Hunter

Enrollment

6

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions

Meningioma

Interventions

DRUG

Ga-68- DOTATATE

"The study intervention consists of two PET scans that will be performed using two different radiotracers, 68-Ga-DOTATATE and 68-Ga-DOTATOC. Ga-68-DOTATATE and 68-Ga-DOTATOC are PET radiotracers targeting somatostatin receptors.~The study intervention consists of 2 PET scans that will be performed at least 24h apart using 68-Ga-DOTATATE and 68-Ga-DOTATOC radiotracers, in patients with suspected meningioma that are planned for subsequent surgery."

DRUG

Ga-68-DOTATOC

"The study intervention consists of two PET scans that will be performed using two different radiotracers, 68-Ga-DOTATATE and 68-Ga-DOTATOC. Ga-68-DOTATATE and 68-Ga-DOTATOC are PET radiotracers targeting somatostatin receptors.~The study intervention consists of 2 PET scans that will be performed at least 24h apart using 68-Ga-DOTATATE and 68-Ga-DOTATOC radiotracers, in patients with suspected meningioma that are planned for subsequent surgery."

Trial Locations (1)

10021

Weill Cornell Medical College of Cornell University, New York